NOVABAY PHARMACEUTICALS, INC. and ________, AS WARRANT AGENT FORM OF PREFERRED STOCK WARRANT AGREEMENT DATED AS OF _______Preferred Stock Warrant Agreement • June 11th, 2009 • NovaBay Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Preferred Stock Warrant Agreement (this “Agreement”), dated as of between NovaBay Pharmaceuticals, Inc., a California corporation (the “Company”) and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
NOVABAY PHARMACEUTICALS, INC. and ________, AS WARRANT AGENT FORM OF COMMON STOCK WARRANT AGREEMENT DATED AS OF _______Common Stock Warrant Agreement • June 11th, 2009 • NovaBay Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Common Stock Warrant Agreement (this “Agreement”), dated as of between NovaBay Pharmaceuticals Inc., a California corporation (the “Company”) and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
NOVABAY PHARMACEUTICALS, INC. and ________, AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OF _______Warrant Agreement • June 11th, 2009 • NovaBay Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Debt Securities Warrant Agreement (this “Agreement”), dated as of between NovaBay Pharmaceuticals, Inc., a California corporation (the “Company”) and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
NOVABAY PHARMACEUTICALS, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [·], 200__ Debt SecuritiesIndenture • June 11th, 2009 • NovaBay Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Indenture, dated as of [·], 200__, among NovaBay Pharmaceuticals, Inc., a California corporation (the “Company”), and [Trustee], as trustee (the “Trustee”):
